Serious Seeds is a Dutch-based company with a long tradition of producing and distributing high quality and potent cannabis seeds. This is actually the core business of Serious Seeds. Now the company is looking to move into CBD. Veritas Farms (OTC: VFRM) is a company from the United States and was one of the industry’s first movers. What do Serous Seeds and Veritas Farms have in common? A commitment to transparency.
Unboxing of CBD oil, notes and application information
If you visit the Serious Seeds website you will quickly note that the company offers a selection of THC laden cannabis, for a long time this was the focus of Serious Seeds. Now things are beginning to change. A search for CBD will reveal 3 products: Two of them are seeds for CBD rich cannabis varieties and the final is the Serious Seeds CBD-Oil containing 10% cannabidiol. The packaging contains all the information you need to know with certificate of qualities, including the all-important information that THC content of the oil is less than 0.2%.
In addition, it is free of pesticides and heavy metals. Serious Seeds also expressly points out that CBD oil is not a medical product, but a food supplement. If you read through all the information on the packaging, you should definitely be able to handle CBD oil responsibly.
There is a dosage recommendation on the box. Three times a day between 3-5 drops are recommended for normal use. The manufacturer recommends not to exceed this dose. The drops are dropped under the tongue, kept under the tongue for one minute and then swallowed. Serious Seeds uses hemp seed oil as a carrier oil. It complements the CBD extract perfectly and is also rich in omega-3 and omega-6 fatty acids. The oil is naturally vegan and gluten-free.
This might sound like Serious Seeds is going to a lot of unnecessary trouble but this hyper-transparent approach works and in fact is the same followed by our American example Veritas Farms.
Veritas Farms – an all American giant in the making
Over the Ocean, on the North-American cannabis market, another company focuses on offering high-quality CBD products to its consumers. Veritas Farms Inc (OTC:VFRM) is a producer and distributor of full spectrum CBD-based products, all coming from its own 140 acre hemp farm and manufacturing facility based in Pueblo, Colorado. In stark contrast to Serious Seeds Veritas Farms has CBD at its very core.
By building its brand around transparency, Veritas has aptly demonstrated the extraordinary potential of the CBD market. Since 2015, the company experienced impressive growth. In Q2, 2019 Veritas generated more than $2.9 million in total revenue. That is a 500% increase since Q2 2018. Veritas’ gross profits reached $1,523,413 and thanks to great results, the company managed to reduce the liabilities by over $1.3 million.
Moreover, Veritas just announced its quarterly results and they are looking very good. In Q3 2019, the company experienced impressive revenue growth, to $1,215,810 compared to $459,329 in Q3 2018, a 165% rise. Also, the company’s gross profits increased by 468% compared to the same period of 2018.
These results allowed Veritas Farms to quickly expand and now its products are sold in more than 5.000 stores across the US, including the last groundbreaking agreements with Winn-Dixie and BI-LO supermarkets to supply CBD to 152 South Eastern stores. Besides, last week, the company announced another astounding partnership with Bi-Mart network.
In addition, the company has just announced a new billboard campaign in the world famous New York Times Square. The campaign is set to generate more than 800,000 impressions a week and will be live during the New Year’s Eve celebrations in the city, providing massive exposure for one of America’s most exciting CBD companies.
The CBD sector is set to take off, and companies focused on offering high-quality CBD products, like Veritas Farms and Serious Seeds, will become the dominant players in the field. The transparent approach to their products has helped build trust in an industry that is often too opaque.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Another biotech gem from Switzerland secures growth capital
A biotech spin-off from the Universities of Zurich and Basel has received new funds from a financing round with renowned...
Industrial espionage costs German companies $229.4 billion
According to the Federation of German Industries (BDI), data theft, industrial espionage and sabotage have cost German companies $229.1 billion...
French Real Estate Crowdfunding grew by 80% in 2019
Real estate crowdfunding is a new way for investors to raise money for their affairs. Crowdfunding for real estate brings...
Growing Capacity: Why Smart Expansion Is Key To Success Among Cannabis Growers
Soaring demand is driving the cannabis market to new highs, as thousands of under served clients can finally obtain their...
Investors react to the Sanofi-Regeneron collaboration
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The...
- Crypto6 days ago
Swiss licensed crypto bank is expanding into 9 new markets
- Biotech6 days ago
Geman Biotech Stocks: Mologen (MGNK) goes insolvent while MorphoSys (MOR) strengthens its position
- Business4 days ago
Where Social Media is Headed in 2020
- Cannabis7 days ago
Brazilian health authority approves registration of cannabis medicines